
GC63707
JB170
Also known as 4-[[9-chloro-7-(2-fluoro-6-methoxyphenyl)-5H-pyrimido[5,4-d][2]benzazepin-2-yl]amino]-N-[2-[2-[2-[[2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxyacetyl]amino]ethoxy]ethoxy]ethyl]-2-methoxybenzamide
JB170 is a potent and highly specific PROTAC-mediated AURORA-A (Aurora Kinase) degrader (DC50=28 nM) by linking Alisertib, to the Cereblon-binding molecule Thalidomide· JB170 preferentially binds AURORA-A (EC50=193 nM) over AURORA-B (EC50=1·4 ?M)· JB170-mediated S-phase arrest is caused specifically by AURORA-A depletion· JB170 has excellent ability to inhibit non-catalytic function of AURORA-A kinase
- CAS number
- 2705844-82-0
- Molecular weight
- 963.36
- Formula
- C48H44ClFN8O11
- Solubility
- DMSO : 100 mg/mL (103·80 mM; Need ultrasonic)
- InChIKey
- GYKNPXCQINZRLL-UHFFFAOYSA-N
- Catalogue number
- GC63707
- Brand
- GLPBIO
Computed properties PubChem CID 153835264 · XLogP 3.7 · TPSA 238 Ų · H-bond donors 4
- XLogP
- 3.7
- TPSA
- 238 Ų
- H-bond donors
- 4
- H-bond acceptors
- 16
- Rotatable bonds
- 19
- Heavy atoms
- 69
SMILES COC1=C(C(=CC=C1)F)C2=NCC3=CN=C(N=C3C4=C2C=C(C=C4)Cl)NC5=CC(=C(C=C5)C(=O)NCCOCCOCCNC(=O)COC6=CC=CC7=C6C(=O)N(C7=O)C8CCC(=O)NC8=O)OC
Computed descriptors from PubChem (CID 153835264), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il